Empirical Results

• Do No Harm? Unintended Consequences Of Pharmaceutical Price Regulation In India
  • Context: Drug Price Control Order 2013
    • The Indian Pharmaceutical Market
    • History of Price Regulation in India
    • Details of DPCO 2013
    • Impact of DPCO on Different Stakeholders
    • Prior Research Results on DPCO 2013
    • Details of Regulations Post DPCO 2013
  • Data and Manipulation Checks
    • Terminology Used
    • Data Preparation and Constructed Variables
    • Constructed Variable: Price Reduction of Regulated SKUs
    • Constructed Variable: Detailing Index of Molecules
    • Price Changes of Unregulated SKUs
  • Empirical Results
    • Summary: Pre and Post Regulation Metrics
    • Difference-in-Difference Results
    • Generalized Synthetic Control Method Results
    • Triangulation Results
    • Summary of Results
    • SKU Wise Results
    • Heterogeneity Analysis
  • Mechanism
    • Lower Detailing of Regulated Drugs
    • Decline in Prescriptions by NonMBBS Physicians
    • Survey Evidence on Detailing – Prescription Correlations
    • Alternative Explanations
  • Conclusions